Alnodesertib is an investigational new drug that is being developed by Artios Pharma for the treatment of solid tumours. It is an ataxia telangiectasia and Rad3 related (ATR) protein inhibitor.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.